Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy

American Journal of Ophthalmology

Volumn 158, Issue 2, 2014, Pages 337-344

  Rush, Ryan B ^a,b,c   Rush, Sloan W ^b,c   Aragon II, Antonio V ^a,b,c   Ysasaga, J Edward ^a,b,c  

^a Southwest Retina Specialists   (United States)

^b Panhandle Eye Group   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CLOPIDOGREL; INDOCYANINE GREEN; WARFARIN;

ADULT; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; FEMALE; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; VERY ELDERLY; VISUAL ACUITY; VITRECTOMY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84905112786     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2014.05.007     Document Type: Article

References (24)

1. L.A. Yannuzzi, J.S. Slakter, and J.A. Sorenson et al. Digital indocyanine green videoangiography and choroidal neovascularization Retina 12 3 1992 191 223
2. L.A. Yannuzzi Indocyanine green angiography: a perspective on use in the clinical setting Am J Ophthalmol 151 5 2011 745 751
3. R.C. Watzke, M.L. Klein, and C.J. Hiner et al. A comparison of stereoscopic fluorescein angiography with indocyanine green videoangiography in age-related macular degeneration Ophthalmology 107 8 2000 1601 1606
4. U. Schneider, H. Kuck, W. Inhoffen, and I. Kreissig Indocyanine green angiographically well-defined choroidal neovascularization: angiographic patterns obtained using the scanning laser ophthalmoscope Ger J Ophthalmol 4 2 1995 67 74
5. S. Wolf, H. Knabben, and G. Krombach et al. Indocyanine-green angiography in patients with occult choroidal neovascularization Ger J Ophthalmol 5 5 1996 251 256
6. D.R. Guyer, L.A. Yannuzzi, and J.S. Slakter et al. Classification of choroidal neovascularization by digital indocyanine green videoangiography Ophthalmology 103 12 1996 2054 2060
7. O. Semoun, B. Guigui, and S. Tick et al. Infrared features of classic choroidal neovascularisation in exudative age-related macular degeneration Br J Ophthalmol 93 2 2009 182 185
8. G. Trabucchi, R. Brancato, and V.D. Molfetta et al. Indocyanine green and fluorescein angiography of surgically excised macular choroidal neovascularizations: correlations with histopathologic and ultrastructural findings Graefes Arch Clin Exp Ophthalmol 234 5 1996 294 299
9. M. Nakajima, H. Shimada, and M. Sato et al. Comparison between indocyanine green angiography and histopathological observations of choroidal neovascular membrane in age-related macular degeneration Nihon Ganka Gakkai Zasshi 101 7 1997 584 592
10. B.L. Lee, J.I. Lim, and H.E. Grossniklaus Clinicopathologic features of indocyanine green angiography-imaged, surgically excised choroidal neovascular membranes Retina 16 1 1996 64 69
11. K. Nishiguchi, A. Obana, and Y. Gohto et al. Classification and visual outcome of choroidal neovascularization in age-related macular degeneration by indocyanine green angiography Jpn J Ophthalmol 44 6 2000 668 676
12. A. Obana, Y. Gohto, and M. Matsumoto et al. Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration Br J Ophthalmol 83 4 1999 429 437
13. T.S. Chang, K.B. Freund, and Z.D.L. Cruz et al. Clinicopathologic correlation of choroidal neovascularization demonstrated by indocyanine green angiography in a patients with retention of good vision for almost four years Retina 14 2 1994 114 124
14. F.K. Avvad, J.S. Duker, and E. Reichel et al. The digital indocyanine green videoangiography characteristics of well-defined choroidal neovascularization Ophthalmology 102 3 1995 401 405
15. O.P. Gupta, G. Shienbaum, and A.H. Patel et al. A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact Ophthalmology 117 11 2010 2134 2140
16. H. Oubraham, S.Y. Cohen, and S. Samimi et al. Inject and extend dosing versus dosing as needed: a comparative retrospective study of ranibizumab in exudative age-related macular degeneration Retina 31 1 2011 26 30
17. G. Shienbaum, O.P. Gupta, and C. Fecarotta et al. Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact Am J Ophthalmol 153 3 2012 468 473
18. R.B. Rush, M.P. Simunovic, L. Vandiver, A.V. Aragon 2nd, and J.E. Ysasaga Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics Retina 34 5 2014 846 852
19. Jumper JM, Mittra RA. American Society of Retina Specialists. Preferences and trends survey, 2012. Available at www.asrs.org/content/documents/2012-asrs- patsurvey-results.pdf. Accessed November 11, 2013.
20. M. Engelbert, S.A. Zweifel, and K.B. Freund "Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation Retina 29 10 2009 1424 1431
21. D.M. Brown, P.K. Kaiser, and M. Michels et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
22. P.J. Rosenfeld, D.M. Brown, and J.S. Heier et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
23. S. Rofagha, R.B. Bhisitkul, and D.S. Boyer et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP) Ophthalmology 120 11 2013 2292 2299
24. G.S. Ying, J. Huang, and M.G. Maguire et al. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ophthalmology 120 1 2013 122 129